News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Forge Biologics' FBX-101, an Innovative AAV Gene Therapy for Krabbe Disease, Granted Innovation Passport Designation in the UK
Wednesday, March 20, 2024Forge Biologics a subsidiary of Ajinomoto BioPharma Services focused on genetic medicine has announced a significant achievement today The Medicines and Healthcare Products Regulatory Agency
Eureka Therapeutics Advances ARYA-3 Clinical Trial to Phase II for Liver Cancer Treatment Utilizing GPC3-Targeting ARTEMIS® T-cell Therapy
Tuesday, March 19, 2024Eureka Therapeutics Inc a leading biotechnology company specializing in Tcell therapies for cancer has announced a significant milestone with its ARYA clinical trial advancing to Phase II
Selvita Introduces Biologic Drug Discovery and Development Services
Monday, March 18, 2024Selvita SA has announced a strategic initiative to expand its service portfolio significantly marking its entry into the field of biologic drug discovery and development This expansion includes the addition of comprehensive capabilities
Biotheus and Hansoh Pharma Expand Collaboration for EGFR/cMET Bispecific Antibody-Drug Conjugate Development
Saturday, March 16, 2024Biotheus Inc and Hansoh Pharmaceutical Group Co Ltd have announced an extension of their strategic collaboration building upon their existing partnership since In this expanded agreement
Charles River and Navega Therapeutics Announce Comprehensive Collaboration for Gene Therapy Manufacturing
Friday, March 15, 2024Charles River Laboratories International Inc and Navega Therapeutics Inc a biotech company specializing in epigenetic gene therapies have recently unveiled a collaborative agreement for an AAV
Antheia and Olon Extend Partnership for Biomanufacturing Essential Raw Materials and Active Pharmaceutical Ingredients
Thursday, March 14, 2024Antheia a company focused on revolutionizing essential medicines supply chains through innovative pharmaceutical ingredients has announced a partnership with Olon Group a prominent player
PureTech Secures Orphan Drug Designation for LYT-200 in Acute Myeloid Leukemia
Thursday, March 14, 2024PureTech Health plc a clinicalstage biotherapeutics company has announced that the US Food and Drug Administration has granted orphan drug designation to LYT for the treatment of AML
Prilenia Plans to Seek Marketing Authorization Application (MAA) Approval for Pridopidine in Huntington’s Disease from the EU
Wednesday, March 13, 2024Prilenia Therapeutics BV a company specializing in the development of innovative therapies for neurodegenerative diseases and neurodevelopmental disorders has announced its intention to submit a Marketing Authorization Application
Astrocyte Pharmaceuticals Receives FDA Clearance for Investigational New Drug Application for AST-004
Wednesday, March 13, 2024Astrocyte Pharmaceuticals Inc a clinicalstage biopharmaceutical company focused on developing therapies for stroke traumatic brain injury and concussion has announced that the US Food and Drug Administration
Pearl Bio Enters Collaboration with Merck for Discovery of Innovative Engineered Biologics
Wednesday, March 13, 2024Pearl Bio a synthetic biology company supported by Khosla Ventures has announced a significant partnership today with Merck known as MSD outside the United States and Canada The collaboration involves a license
